Study finds hospital involvement in Medicare ACOs does not significantly change emergency department admission rates, length of stay, or costs, suggesting current ACO models have limited impact on acute care spending.

Explore Medicare coverage limitations for Saxenda, a GLP-1 agonist approved for weight loss, and the implications for obesity drug access and insurance plan strategies.

Medicare Part D enrollees may face significant premium hikes up to $50 monthly in 2025 due to increased drug spending, policy changes, and reduced federal stabilization funding. Compare plans during open enrollment.

New York State's failure to enforce Medicare enrollment for eligible seniors costs Medicaid $500 million amidst federal funding cuts, raising concerns over state health spending and oversight.

Congressional bill aims to improve Medicare Advantage comparisons by using accurate data and transparent methods, ensuring fair Medicare policy for seniors and taxpayers.

Mississippi GOP primaries highlight opposition to Medicaid expansion amid legislative debates and new federal healthcare laws. Governor Reeves maintains his stance against Medicaid expansion.

A summary of STAT's health policy news coverage and subscription-based access, highlighting vaccine skepticism and Medicare's 60th anniversary within U.S. healthcare context.

Minnesota's new law introduces phased Medicaid cuts affecting eligibility, healthcare funding, and rural hospitals, with significant administrative and enrollment impacts.

The Trump administration proposes a Medicare and Medicaid pilot program for covering GLP-1 weight loss drugs, marking a key shift in healthcare policy and potential budget impacts.

Study reveals Medicare spends $4.4 billion annually on low-value tests and procedures in older adults, urging evidence-based reforms to reduce waste and enhance care quality.